List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #52,841 to #52,890.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. The Living Guidelines: Maintenance of sinus rhythm: View the Current CLASS III Guidelines → Atrial fibrillation maintenance of sinus rhythm
  2. The Living Guidelines: Maintenance of sinus rhythm: View the Current CLASS IIa Guidelines → Atrial fibrillation maintenance of sinus rhythm
  3. The Living Guidelines: Maintenance of sinus rhythm: View the Current CLASS I Guidelines → Atrial fibrillation maintenance of sinus rhythm
  4. The Living Guidelines: Patients at High Risk for Developing Heart Failure. View the Current CLASS III Guidelines → Congestive heart failure treatment of patients at high risk for developing heart failure (Stage A)
  5. The Living Guidelines: Patients at High Risk for Developing Heart Failure. View the Current CLASS IIa Guidelines → Congestive heart failure treatment of patients at high risk for developing heart failure (Stage A)
  6. The Living Guidelines: Patients at High Risk for Developing Heart Failure. View the Current CLASS I Guidelines → Congestive heart failure treatment of patients at high risk for developing heart failure (Stage A)
  7. The Living Guidelines: Patients with Cardiac Structural Abnormalities or Remodeling who have not Developed Heart Failure Symptoms. View the Current CLASS III Guidelines → Congestive heart failure treatment of patients with cardiac structural abnormalities or remodeling who have not developed heart failure symptoms (Stage B)
  8. The Living Guidelines: Patients with Cardiac Structural Abnormalities or Remodeling who have not Developed Heart Failure Symptoms. View the Current CLASS IIa Guidelines → Congestive heart failure treatment of patients with cardiac structural abnormalities or remodeling who have not developed heart failure symptoms (Stage B)
  9. The Living Guidelines: Patients with Cardiac Structural Abnormalities or Remodeling who have not Developed Heart Failure Symptoms. View the Current CLASS IIb Guidelines → Congestive heart failure treatment of patients with cardiac structural abnormalities or remodeling who have not developed heart failure symptoms (Stage B)
  10. The Living Guidelines: Patients with Cardiac Structural Abnormalities or Remodeling who have not Developed Heart Failure Symptoms. View the Current CLASS I Guidelines → Congestive heart failure treatment of patients with cardiac structural abnormalities or remodeling who have not developed heart failure symptoms (Stage B)
  11. The Living Guidelines: Patients with Heart Failure and Normal LVEF. View the Current CLASS IIa Guidelines → Congestive heart failure treatment of patients with current or prior symptoms of heart failure (Stage C)
  12. The Living Guidelines: Patients with Heart Failure and Normal LVEF. View the Current CLASS IIb Guidelines → Congestive heart failure treatment of patients with current or prior symptoms of heart failure (Stage C)
  13. The Living Guidelines: Patients with Heart Failure and Normal LVEF. View the Current CLASS I Guidelines → Congestive heart failure treatment of patients with current or prior symptoms of heart failure (Stage C)
  14. The Living Guidelines: Patients with Heart Failure who have Concomitant Disorders. View the Current CLASS III Guidelines → Congestive heart failure treatment of patients who have concomitant disorders
  15. The Living Guidelines: Patients with Heart Failure who have Concomitant Disorders. View the Current CLASS IIa Guidelines → Congestive heart failure treatment of patients who have concomitant disorders
  16. The Living Guidelines: Patients with Heart Failure who have Concomitant Disorders. View the Current CLASS IIb Guidelines → Congestive heart failure treatment of patients who have concomitant disorders
  17. The Living Guidelines: Patients with Heart Failure who have Concomitant Disorders. View the Current CLASS I Guidelines → Congestive heart failure treatment of patients who have concomitant disorders
  18. The Living Guidelines: Patients with Pulmonary Hypertension: View the Current CLASS III Guidelines → Atrial fibrillation pulmonary diseases
  19. The Living Guidelines: Patients with Pulmonary Hypertension: View the Current CLASS I Guidelines → Atrial fibrillation pulmonary diseases
  20. The Living Guidelines: Patients with Reduced LVEF. View the Current CLASS III Guidelines → Congestive heart failure treatment of patients with current or prior symptoms of heart failure (Stage C)
  21. The Living Guidelines: Patients with Reduced LVEF. View the Current CLASS IIa Guidelines → Congestive heart failure treatment of patients with current or prior symptoms of heart failure (Stage C)
  22. The Living Guidelines: Patients with Reduced LVEF. View the Current CLASS IIb Guidelines → Congestive heart failure treatment of patients with current or prior symptoms of heart failure (Stage C)
  23. The Living Guidelines: Patients with Reduced LVEF. View the Current CLASS I Guidelines → Congestive heart failure treatment of patients with current or prior symptoms of heart failure (Stage C)
  24. The Living Guidelines: Patients with Refractory End-Stage Heart Failure. View the Current CLASS III Guidelines → Congestive heart failure treatment of patients with refractory end-stage heart failure (Stage D)
  25. The Living Guidelines: Patients with Refractory End-Stage Heart Failure. View the Current CLASS IIa Guidelines → Congestive heart failure treatment of patients with refractory end-stage heart failure (Stage D)
  26. The Living Guidelines: Patients with Refractory End-Stage Heart Failure. View the Current CLASS IIb Guidelines → Congestive heart failure treatment of patients with refractory end-stage heart failure (Stage D)
  27. The Living Guidelines: Patients with Refractory End-Stage Heart Failure. View the Current CLASS I Guidelines → Congestive heart failure treatment of patients with refractory end-stage heart failure (Stage D)
  28. The Living Guidelines: Patients with Wolff Parkinson White syndrome (WPW): View the Current CLASS III Guidelines → Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes
  29. The Living Guidelines: Patients with Wolff Parkinson White syndrome (WPW): View the Current CLASS IIa Guidelines → Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes
  30. The Living Guidelines: Patients with Wolff Parkinson White syndrome (WPW): View the Current CLASS IIb Guidelines → Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes
  31. The Living Guidelines: Patients with Wolff Parkinson White syndrome (WPW): View the Current CLASS I Guidelines → Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes
  32. The Living Guidelines: Patients with acute myocardial infarction: View the Current CLASS III Guidelines → Atrial fibrillation acute myocardial infarction
  33. The Living Guidelines: Patients with acute myocardial infarction: View the Current CLASS IIa Guidelines → Atrial fibrillation acute myocardial infarction
  34. The Living Guidelines: Patients with acute myocardial infarction: View the Current CLASS I Guidelines → Atrial fibrillation acute myocardial infarction
  35. The Living Guidelines: Patients with hyperthyroidism: View the Current CLASS I Guidelines → Atrial fibrillation hyperthyroidism
  36. The Living Guidelines: Patients with hypertrophic cardiomyopathy: View the Current CLASS IIa Guidelines → Atrial fibrillation hypertrophic cardiomyopathy
  37. The Living Guidelines: Patients with hypertrophic cardiomyopathy: View the Current CLASS I Guidelines → Atrial fibrillation hypertrophic cardiomyopathy
  38. The Living Guidelines: Patients with postoperative atrial fibrillation: View the Current CLASS IIa Guidelines → Postoperative atrial fibrillation
  39. The Living Guidelines: Patients with postoperative atrial fibrillation: View the Current CLASS IIb Guidelines → Postoperative atrial fibrillation
  40. The Living Guidelines: Patients with postoperative atrial fibrillation: View the Current CLASS I Guidelines → Postoperative atrial fibrillation
  41. The Living Guidelines: Pharmacological Cardioversion of Atrial Fibrillation View the Current CLASS III Guidelines → Atrial fibrillation cardioversion
  42. The Living Guidelines: Pharmacological Cardioversion of Atrial Fibrillation View the Current CLASS IIa Guidelines → Atrial fibrillation cardioversion
  43. The Living Guidelines: Pharmacological Cardioversion of Atrial Fibrillation View the Current CLASS IIb Guidelines → Atrial fibrillation cardioversion
  44. The Living Guidelines: Pharmacological Cardioversion of Atrial Fibrillation View the Current CLASS I Guidelines → Atrial fibrillation cardioversion
  45. The Living Guidelines: Pharmacological enhancement of direct-current cardioversion: View the Current CLASS IIa Guidelines → Atrial fibrillation cardioversion
  46. The Living Guidelines: Pharmacological enhancement of direct-current cardioversion: View the Current CLASS IIb Guidelines → Atrial fibrillation cardioversion
  47. The Living Guidelines: Pharmacological rate control during atrial fibrillation View the Current CLASS III Guidelines → Atrial fibrillation rate control
  48. The Living Guidelines: Pharmacological rate control during atrial fibrillation View the Current CLASS IIa Guidelines → Atrial fibrillation rate control
  49. The Living Guidelines: Pharmacological rate control during atrial fibrillation View the Current CLASS IIb Guidelines → Atrial fibrillation rate control
  50. The Living Guidelines: Pharmacological rate control during atrial fibrillation View the Current CLASS I Guidelines → Atrial fibrillation rate control

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:ListRedirects"